Please login to the form below
National Cancer Institute
This page shows the latest National Cancer Institute news and features for those working in and with pharma, biotech and healthcare.
AZ nabs US approval for new leukaemia drug Lumoxiti
National Cancer Institute (NCI) in the US, the lead investigator in the study. ... Seattle Genetics/Takeda’ s classical Hodgkin lymphoma therapy Adcetris (brentuximab vedotin) and Roche’s Kadcyla (trastuzumab emtansine) for breast cancer.
Latest news
-
Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m
Professor David Marks, Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, and transplant co-ordinator of the National Cancer Research Institute (NCRI) Adult ALL Group said the
-
ACT immunotherapy cures terminal breast cancer patient
ACT immunotherapy cures terminal breast cancer patient. The new approach focuses on mutations rather than cancer type. ... The new approach - a modified version of a technique known as adoptive cell transfer (ACT) - is being developed by researchers at
-
Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment
Some key ASCO takeways:. Merck’s Keytruda once again demonstrated its efficacy in non-small cell lung cancer, with two new studies hitting their endpoints. ... the US National Cancer Institute sponsored trial provides definitive evidence that a simple
-
Celgene boosts CAR-T stake again with Bluebird Bio deal
At the time, lead investigator James Kochenderfer from the Center for Cancer Research at the National Cancer Institute in Bethesda said: “We have patients who have a sustained response and have ... and a $1.1bn agreement to acquire Impact Biomedicines
-
Merck and Pfizer claim second FDA nod for cancer drug Bavencio
first approval as a treatment for the skin cancer Merkel cell carcinoma (MCC). ... Commenting on the new approval, Andrea Apolo, an oncologist at National Cancer Institute in the US, said: "Once UC progresses after treatment with chemotherapy, the
More from news
Approximately 2 fully matching, plus 85 partially matching documents found.
Latest Intelligence
-
30 women leaders in UK healthcare (part 3)
As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of
-
An effective commercial model for cancer care
Treatments for cancer are among the most expensive of all, regardless of disease. ... In an online survey of 8, 411 cancer patients administered by LIVESTRONG (the Lance Armstrong Foundation) and the National Cancer Institute's Health Information
-
EATRIS and the new age of partnering
In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... In October the National Cancer Institute will meet with specialists -
-
Diagnostics are rising up the pharma value chain
According to the US National Cancer Institute, about 12 per cent of women in the general population will develop breast cancer sometime during their lives. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.
-
Country report: The healthcare market in France
National Cancer Institute (NCI) or the National Institute for Prevention and Education for Health (NIPEH). ... This applies to oncology drugs under France's national cancer care plan that includes fast access to new therapies.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Celgene boosts CAR-T stake again with Bluebird Bio deal
At the time, lead investigator James Kochenderfer from the Center for Cancer Research at the National Cancer Institute in Bethesda said: “We have patients who have a sustained response and have ... and a $1.1bn agreement to acquire Impact Biomedicines
-
Cancer Research UK's Karen Vousden to join BMS board
She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National ... Cancer Institute.
-
AZ and Medimmune bolsters immuno-oncology leadership
at the National Cancer Institute (NCI). ... Institut Gustave Roussy - a leading cancer-research institute.
-
Iris Pauporté joins OSE Immunotherapeutics
Pauporté will lead the clinical development of the firm's lung cancer candidate Tedopi, which is currently in phase III trials, and will be responsible for exploring the drug's potential ... She brings over 20 years of biomedical and clinical research
-
AstraZeneca appoints Sean Bohen as chief medical officer
Before joining Genentech he was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the ... National Cancer Institute.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Mastering the precision medicine opportunity
The 4ps of Precision Medicine. The National Cancer Institute and the Centre for Disease Control both use the 4Ps model to define precision medicine, considering it a form of evidence-based ... Parallel to the increasing number of testing options is the
-
ASCO 2015: What you missed in Chicago
Specifically, we thought the checkpoint inhibitors in head and neck, lung cancer and melanoma really shone. ... Personalised treatments: targeting genetic mutations to treat cancer. The second area that really impressed me was the large National Cancer
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Healthcare PR Senior Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Salary is DOE
- Medical Writers Required - Hertfordshire
-
Competitive
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Associate Scientific Director
-
Salary TBC
- Sudler London - Senior Medical Writer
-
Competitive
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Account Manager
-
Negotiable
-
Sudler London - Account Director
-
Competitive
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- Lucid limbers up for second annual sports day
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- Hanover Health launches award, Firstlight spins off healthcare arm and more
- J&J files ‘breakthrough’ bladder cancer drug in US
- Boehringer’s Corsico to be new GSK drug dev leader
- More tell, less sell: HCP-centric comms
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
